openPR Logo
Press release

China Lung Cancer Screening Market to Grow at 11.2% CAGR from 2025 to 2032 - Persistence Market Research

08-07-2025 07:14 AM CET | Health & Medicine

Press release from: Persistence Market Research

China Lung Cancer Screening Market

China Lung Cancer Screening Market

Lung cancer continues to be one of the leading causes of death worldwide, and China is no exception. The country, which faces a high burden of the disease, is increasingly prioritizing early detection through advanced lung cancer screening methods. The China Lung Cancer Screening Market is projected to reach US$ 1,295.5 million by 2032, up from US$ 616.2 million in 2025, witnessing a robust compound annual growth rate (CAGR) of 11.2% over the forecast period. This market expansion is largely driven by government-backed initiatives, technological advancements, and increased public awareness of lung cancer prevention. According to Persistence Market Research, the demand for innovative lung cancer screening solutions is expected to grow substantially, spurred by the rising prevalence of lung cancer and the continued push for early-stage detection.

In China, lung cancer remains the most common type of cancer, with over 700,000 lives claimed annually. Despite improvements in medical technologies, most cases are still diagnosed at advanced stages, where treatment options are often limited and survival rates are poor. This challenge has highlighted the urgent need for widespread, effective screening programs. Low-Dose Computed Tomography (LDCT) has emerged as a key diagnostic tool, offering hope for earlier detection and improved outcomes. The implementation of LDCT, backed by both governmental policy and local healthcare efforts, is central to China's strategy for reducing lung cancer mortality.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35427

Market Statistics and Growth Drivers

The lung cancer screening market in China is experiencing rapid growth. The current market size stands at approximately US$ 616.2 million in 2025 and is expected to double by 2032, reflecting a notable CAGR of 11.2%. This growth can be attributed to several key factors. The foremost of these is the increasing burden of lung cancer in China, combined with a growing recognition of the benefits of early-stage detection. Government efforts, such as the National Cancer Screening Program (NCSP), have also significantly boosted the market by integrating lung cancer into broader national health initiatives. These steps are helping to reduce the fatality rate associated with lung cancer through widespread screening programs that target high-risk populations.

Among the various diagnostic tools, the LDCT scan is set to dominate the market, with a forecasted share of 71.4% in 2025. The scan's superior ability to detect lung cancer at earlier stages is contributing to its growing adoption. Shandong and Sichuan are among the provinces showing notable growth due to the strong uptake of LDCT, with both regions developing targeted screening programs aimed at high-risk individuals. However, the market is not without its challenges, including issues like low patient compliance and high false-positive rates. Nevertheless, the growth trajectory for the market remains strong, buoyed by continued technological advancements and strategic collaborations between public health bodies and the private sector.

Key Highlights from the Report

➤ China's lung cancer screening market is expected to grow at a CAGR of 11.2% from 2025 to 2032.
➤ Government-backed initiatives are accelerating the adoption of LDCT for early lung cancer detection.
➤ The LDCT scan is projected to capture 71.4% of the market share by 2025.
➤ Non-Small Cell Lung Cancer (NSCLC) will hold the largest market share due to its high prevalence.
➤ Shandong province is witnessing strong uptake of lung cancer screening due to targeted government programs.
➤ AI-based technologies are expected to drive innovation in early-stage lung cancer detection.

Market Segmentation

Product Type Segmentation

The China lung cancer screening market is primarily segmented based on the type of diagnostic technology used. The key diagnostic tools include Low-Dose Computed Tomography (LDCT) and chest X-ray. LDCT is by far the most widely used screening method due to its high sensitivity in detecting early-stage lung cancers. LDCT's ability to detect lung cancer in high-risk individuals, including non-smokers, has made it a crucial element of national cancer screening programs. As of 2025, LDCT is anticipated to hold around 71.4% of the market share, reflecting its superior performance and widespread acceptance in both urban and rural areas.

On the other hand, chest X-ray (CXR) is expected to remain a significant tool for lung cancer diagnosis in China. While CXR lacks the precision and sensitivity of LDCT, it continues to play an essential role in increasing public awareness about lung cancer and engaging people in early-stage screening efforts. As per surveys conducted in Sichuan, introducing CXR in routine check-ups led to a nearly 1.6-fold increase in public awareness. This makes it a valuable complement to LDCT, especially in less developed regions where LDCT infrastructure is still limited.

End-User Segmentation

The primary end-users of lung cancer screening solutions in China include hospitals, diagnostic centers, and research institutions. Hospitals remain the largest consumer of screening tools due to their access to advanced imaging technologies and higher patient volumes. Within hospitals, both public and private institutions are increasingly adopting LDCT to meet government screening targets and improve early detection rates. Diagnostic centers, especially those located in urban areas, are also seeing growing demand for lung cancer screening tools, as they serve as accessible hubs for high-risk individuals seeking routine health check-ups.

Moreover, with the increasing availability of mobile screening services and tele-radiology platforms, diagnostic centers in rural or underdeveloped areas are likely to experience higher demand for affordable, portable lung cancer screening technologies. Research institutions are another key market segment, particularly as studies into AI-assisted diagnostic tools gain momentum. These institutions are investing in developing new technologies and models that can improve the sensitivity and accuracy of screening methods.

✅Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/china-lung-cancer-screening-market.asp

Regional Insights

Trends in Shandong

Shandong province is among the leaders in lung cancer screening in China, owing to its high incidence of lung cancer and the implementation of targeted government programs. In 2018, Shandong recorded an age-standardized incidence rate (ASIR) of 42.56 per 100,000 people, significantly higher than the national average. In response to this, the province has adopted the National Lung Cancer Screening (NLCS) framework, which recommends LDCT screening for individuals aged 50 to 75 with a smoking history or other risk factors. The region's success can be attributed to efforts like optimized scan parameters, annual or biennial follow-ups, and public education campaigns.

Trends in Sichuan

Sichuan has seen considerable improvements in lung cancer screening uptake, with over 95% of high-risk individuals now within a 60-minute radius of an LDCT screening facility. However, significant regional disparities remain. While urban areas benefit from better access to healthcare services, rural and ethnic minority regions still face barriers to effective screening. To address these issues, provincial authorities have increased efforts to improve accessibility, including providing transportation assistance and reducing wait times. Despite these challenges, Sichuan's initiatives show promising results in improving screening uptake and reducing lung cancer mortality in high-risk populations.

Market Drivers

The growth of the China lung cancer screening market is primarily driven by governmental support for early cancer detection programs, including funding, regulatory frameworks, and guidelines. The NCSP's integration of lung cancer into national screening programs has made early detection a priority, particularly in high-risk populations. Additionally, technological advancements in imaging, including AI-assisted diagnostics, are creating new opportunities for more accurate and efficient screening, further propelling market growth.

Market Restraints

Despite these favorable drivers, the market faces significant challenges. A major restraint is the uneven uptake of lung cancer screening programs. In regions like Henan, only 40% of individuals invited for LDCT completed the screening, highlighting issues like out-of-pocket costs, distrust in healthcare institutions, and lack of awareness. Moreover, high false-positive rates associated with LDCT have led to increased anxiety, additional costs for follow-up imaging, and unnecessary treatments, further discouraging participation in screening programs.

Market Opportunities

One of the most promising opportunities in the market is the incorporation of AI technologies in lung cancer detection. AI systems have shown remarkable accuracy in identifying lung cancer at earlier stages, and their integration into LDCT screening has the potential to improve diagnostic outcomes. Additionally, mobile screening units and tele-radiology platforms can help extend screening access to underserved regions, making early detection more widespread and equitable.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35427

Reasons to Buy the Report

✔ Comprehensive insights into the growth potential of the China lung cancer screening market from 2025 to 2032.
✔ In-depth analysis of government-backed initiatives driving early detection efforts in China.
✔ Detailed segmentation analysis, helping businesses target high-growth areas effectively.
✔ Updated market dynamics, including drivers, restraints, and emerging opportunities.
✔ Competitive landscape insights, helping companies identify key players and new technologies.

Company Insights

The China lung cancer screening market is home to several prominent global and domestic companies, which are driving innovations in diagnostic technology and increasing market competition. Key players in the market include:

✦ Biodesix
✦ GE HealthCare
✦ DELFI Diagnostics, Inc.
✦ Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
✦ CANON MEDICAL SYSTEMS CORPORATION
✦ Siemens Healthineers AG
✦ Medtronic plc
✦ Koninklijke Philips N.V.
✦ Freenome Holdings, Inc.
✦ Shanghai United Imaging Healthcare Co., LTD.

Recent Developments

In April 2025, researchers at the Guangzhou Institute of Respiratory Disease discovered that lung cancer screening detected non-smokers at comparable rates to smokers using low-dose CT.

In January 2025, a study at Sichuan University found that only 23.88% of urban residents had adequate awareness about lung cancer, indicating the need for greater public health outreach.

The future of the China lung cancer screening market looks promising, fueled by technological advancements, government support, and the ongoing push for early-stage cancer detection. With an increasing focus on AI and mobile solutions, the market is set to become more accessible, accurate, and efficient in identifying at-risk individuals.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release China Lung Cancer Screening Market to Grow at 11.2% CAGR from 2025 to 2032 - Persistence Market Research here

News-ID: 4136221 • Views:

More Releases from Persistence Market Research

Global Automotive Active Health Monitoring Systems Market Expected to Surge from US$ 683.9 Mn in 2025 to US$ 2,338.3 Mn by 2032 at 19.2% CAGR | Persistence Market Research
Global Automotive Active Health Monitoring Systems Market Expected to Surge from …
The Automotive Active Health Monitoring Systems Market is poised for significant growth over the forecast period of 2025 to 2032. This market is projected to expand from USD 683.9 million in 2025 to USD 2,338.3 million by 2032, registering a robust CAGR of 19.20%. Automotive active health monitoring systems are designed to track the real-time status of vehicles, enabling predictive maintenance, reducing downtime, and enhancing overall vehicle safety. With growing
Primary Packaging Labels Market to Reach US$12.2 Bn by 2031 with Steady Growth at 3.3% CAGR - Persistence Market Research
Primary Packaging Labels Market to Reach US$12.2 Bn by 2031 with Steady Growth a …
➤Overview of the Market The global primary packaging labels market is a crucial segment of the packaging industry, enabling product identification, regulatory compliance, and brand differentiation. Primary labels are applied directly on product packaging, such as bottles, vials, boxes, and pouches, serving both functional and promotional roles. As consumer awareness of product authenticity and safety continues to rise, demand for innovative labeling solutions is expanding. Moreover, stringent regulatory frameworks in industries
Shelf Stable Packaging Market to Reach US$10.7 Bn by 2031 with Steady Growth at 2.4% CAGR - Persistence Market Research
Shelf Stable Packaging Market to Reach US$10.7 Bn by 2031 with Steady Growth at …
➤Overview of the Market The shelf stable packaging market plays a critical role in extending the shelf life of food and beverages without the need for refrigeration, ensuring product safety, convenience, and affordability. These packaging solutions-spanning cartons, pouches, cans, and plastic containers-are widely used in ready-to-eat meals, dairy alternatives, sauces, soups, and beverages. Growth in the market is closely linked to evolving consumer lifestyles, increasing urbanization, and demand for long-lasting packaged
Print Label Market to Reach US$68.6 Bn by 2031 with Steady Growth at 4.3% CAGR - Persistence Market Research
Print Label Market to Reach US$68.6 Bn by 2031 with Steady Growth at 4.3% CAGR - …
➤Overview of the Market The global print label market is poised for substantial expansion, driven by increasing demand across industries such as food & beverages, pharmaceuticals, cosmetics, and logistics. Labels play a crucial role in brand identity, product differentiation, and regulatory compliance. In addition to providing essential information like product ingredients, expiration dates, and barcodes, printed labels serve as key marketing tools that influence consumer purchase decisions. With the rapid rise

All 5 Releases


More Releases for China

China fund establishment, China fund management,china investment management
Pandacu China is a leading financial institution that specializes in providing fund establishment and management services for domestic and international investors looking to invest in China. The company was founded in 2015 by a team of experienced finance professionals with a deep understanding of the Chinese market and a strong network of contacts in the investment industry. https://boomingfaucet.com/ China Fund Establishment Consultation E-mail:nolan@pandacuads.com Investing in China can be a complex and challenging process, and
China Finance Advisor, China Debt Finance Corporation,China Investment Corporati …
Investment bank is a financial institution that helps companies and governments raise capital by underwriting and issuing securities, and also provides advice on mergers and acquisitions, strategic investments, and other financial matters. Investment banks typically have a team of professionals with expertise in various areas such as corporate finance, securities underwriting, sales and trading, and market research. http://pandacuads.com/ China Investment Corporation Email:nolan@pandacuads.com Some of the main services provided by investment banks include: Underwriting: Investment banks
China Investment Bank, China Investment Consultant, China Investment Corporation …
Pandacu is a company that specializes in cross-border investment in China. The company was founded in china and has since grown to become one of the leading cross-border investment firms in China. Pandacu offers a wide range of services to its clients, including investment advisory, market research, due diligence, and post-investment support. http://pandacuads.com/ Investment banking consultant Email:nolan@pandacuads.com Cross-border investment in China can be a complex and challenging process, as the country has a unique
china construction company,china engineering company,china major bridge engineer …
List of Top 500 Chinese Construction Enterprises ranking https://gzwatches.cn/ Free engineering construction consultation Email:nolan@wholsale9.com Company Name province 1 China State Construction Corporation Limited Beijing 2 China Railway Corporation Limited Beijing 3 China Railway Construction Corporation Limited Beijing 4 Shanghai Weimengsi Construction Engineering Co., Ltd. Shanghai 5 China Communications Construction Group Co., Ltd. Beijing 6 China Power Construction Corporation Limited Beijing 7 China Energy Construction Group Co., Ltd. Beijing 8 Shanghai Construction Engineering Group Co., Ltd. Shanghai 9 Jiangsu Zhongnan Construction Industry Group Co., Ltd. Jiangsu 10 China Gezhouba Group Co., Ltd. Hubei 11 China National Chemical Engineering Co., Ltd. Beijing 12 Sinoma Group Co., Ltd. Beijing 13 Guangxi Construction Engineering Group Co., Ltd. Guangxi 14 Shanghai Urban
Forehead Thermometer Market Analysis (2019- 2025)| Microlife (China), Radiant (C …
This research study is one of the most detailed and accurate ones that solely focus on the global Forehead Thermometer market. It sheds light on critical factors that impact the growth of the global Forehead Thermometer market on several fronts. Market participants can use the report to gain a sound understanding of the competitive landscape and strategies adopted by leading players of the global Forehead Thermometer market. The authors of
Global Color Steel Tile Market 2017 - South China, East China, Southwest China, …
Color Steel Tile Market Research Report A market study based on the " Color Steel Tile Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Color Steel Tile Market 2017’. The research report analyses the historical as well as present performance of the worldwide Color Steel Tile industry, and makes predictions on the future status of Color Steel Tile market on the basis